Literature DB >> 29086145

Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly.

Elodie Jean-Bart1,2, Claire Moutet3, Virginie Dauphinot4, Pierre Krolak-Salmon3,5,6,4, Christelle Mouchoux7,3,6,4.   

Abstract

Background There are several assessment scales to evaluate the risk of falls or the adverse drug reaction risk. Few are sufficiently specific to assess the impact of drug prescriptions on falls in geriatric populations. Objective To define the risk of anticholinergic and sedation-related ADRs in an elderly hospitalized patient population using the Drug Burden Index (DBI), Anticholinergic Drug Scale (ADS), and Sedative Load Model (SLM). Setting Five geriatric university hospital centers in France. Method Multicenter prospective cohort study from 2011 to 2013. Drug prescriptions were compiled to estimate anticholinergic and sedative exposure. Any associations between the drug scales and falls were assessed. Main outcome measure Drug exposure estimated with the DBI, ADS, and SLM scales. Results 315 patients, with a mean age of 87 years and 117 documented falls, were included from 5 geriatric hospitals. Sixty-one percent of these patients had a DBI > 0, 20.3% had an ADS ≥ 3, 56.2% a SLM > 0. No association was detected between the scores and the risk of a fall (p > 0.05). Factors significantly associated with a risk of a fall were: a prior history of a fall in the previous 12 months (adjusted odds ratio [aOR] = 7.24, 4.06-12.89), orthostatic hypotension ([aOR] = 2.84; 1.39-5.79), or prescription of antidepressants ([aOR] = 2.12; 1.17-3.84). Conclusion A specific scale to identify high-risk prescriptions would help clinicians and pharmacists to optimize therapeutic treatments for the elderly. In light of the multifactorial characteristics of falls, predicting their risk should be based on a well-defined set of factors.

Entities:  

Keywords:  Adverse effects; Aged; Anticholinergic medication; Falls; France; Pharmaceutical care; Sedative medication

Mesh:

Substances:

Year:  2017        PMID: 29086145     DOI: 10.1007/s11096-017-0533-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  50 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Associations between drug burden index and mortality in older people in residential aged care facilities.

Authors:  Nicholas M Wilson; Sarah N Hilmer; Lyn M March; Jian Sheng Chen; Danijela Gnjidic; Rebecca S Mason; Ian D Cameron; Philip N Sambrook
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

3.  Helping pharmacists to reduce fall risk in long-term care: A clinical tool to facilitate the medication review process.

Authors:  Carlos H Rojas-Fernandez; Nicole Seymour; Susan G Brown
Journal:  Can Pharm J (Ott)       Date:  2014-05

4.  Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort.

Authors:  Virginie Dauphinot; Rémi Faure; Sélim Omrani; Sylvain Goutelle; Laurent Bourguignon; Pierre Krolak-Salmon; Christelle Mouchoux
Journal:  J Clin Psychopharmacol       Date:  2014-10       Impact factor: 3.153

5.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

Review 6.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons.

Authors:  John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra
Journal:  Arch Intern Med       Date:  2009-11-23

7.  Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes.

Authors:  M E Tinetti; S K Inouye; T M Gill; J T Doucette
Journal:  JAMA       Date:  1995-05-03       Impact factor: 56.272

8.  The anticholinergic risk scale and anticholinergic adverse effects in older persons.

Authors:  James L Rudolph; Marci J Salow; Michael C Angelini; Regina E McGlinchey
Journal:  Arch Intern Med       Date:  2008-03-10

9.  A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

Authors:  M E Tinetti; D I Baker; G McAvay; E B Claus; P Garrett; M Gottschalk; M L Koch; K Trainor; R I Horwitz
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

10.  Identifying older people at high risk of future falls: development and validation of a screening tool for use in emergency departments.

Authors:  Anne Tiedemann; Catherine Sherrington; Teresa Orr; Jamie Hallen; Donna Lewis; Ann Kelly; Constance Vogler; Stephen R Lord; Jacqueline C T Close
Journal:  Emerg Med J       Date:  2012-11-08       Impact factor: 2.740

View more
  3 in total

1.  Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries.

Authors:  Shahar Shmuel; Virginia Pate; Marc J Pepin; Janine C Bailey; Laura C Hanson; Til Stürmer; Rebecca B Naumann; Yvonne M Golightly; Danijela Gnjidic; Jennifer L Lund
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-15       Impact factor: 2.890

2.  Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study.

Authors:  Patricia Amoros-Reboredo; Dolors Soy; Marta Hernandez-Hernandez; Sabela Lens; Conxita Mestres
Journal:  Int J Environ Res Public Health       Date:  2020-05-26       Impact factor: 3.390

Review 3.  Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.

Authors:  Angela Lisibach; Valérie Benelli; Marco Giacomo Ceppi; Karin Waldner-Knogler; Chantal Csajka; Monika Lutters
Journal:  Eur J Clin Pharmacol       Date:  2020-10-03       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.